T2 Biosystms Stock Buy Hold or Sell Recommendation

TTOO Stock  USD 0.50  0.04  7.41%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding T2 Biosystms is 'Strong Sell'. Macroaxis provides T2 Biosystms buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TTOO positions. The advice algorithm takes into account all of T2 Biosystms' available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from T2 Biosystms' buy-and-hold perspective. Check out T2 Biosystms Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in T2 Biosystms Stock please use our How to Invest in T2 Biosystms guide.We conduct extensive research on individual companies such as T2 Biosystms and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards T2 Biosystms.

Execute T2 Biosystms Buy or Sell Advice

The T2 Biosystms recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on T2 Biosystms. Macroaxis does not own or have any residual interests in T2 Biosystms or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute T2 Biosystms' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell T2 BiosystmsBuy T2 Biosystms
Strong Sell



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

For the selected time horizon T2 Biosystms has a Mean Deviation of 4.8, Standard Deviation of 7.04 and Variance of 49.53
We provide trade recommendation to complement the latest expert consensus on T2 Biosystms. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at this moment. To make sure T2 Biosystms is not overpriced, please validate all T2 Biosystms fundamentals, including its shares owned by insiders, total debt, retained earnings, as well as the relationship between the revenue and earnings per share . As T2 Biosystms appears to be a penny stock we also recommend to double-check its price to earning numbers.

T2 Biosystms Trading Alerts and Improvement Suggestions

T2 Biosystms generated a negative expected return over the last 90 days
T2 Biosystms has high historical volatility and very poor performance
T2 Biosystms has some characteristics of a very speculative penny stock
T2 Biosystms has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 28.06 M. Net Loss for the year was (49.24 M) with loss before overhead, payroll, taxes, and interest of (24.77 M).
T2 Biosystms currently holds about 13.21 M in cash with (38.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from kalkinemedia.com: T2 Biosystems Affirms Plans To Add Candida Auris Detection To The FDA-Cleared T2candida Panel

T2 Biosystms Returns Distribution Density

The distribution of T2 Biosystms' historical returns is an attempt to chart the uncertainty of T2 Biosystms' future price movements. The chart of the probability distribution of T2 Biosystms stock daily returns describes the distribution of returns around its average expected value. We use T2 Biosystms price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of T2 Biosystms returns is essential to provide solid investment advice for T2 Biosystms.
Mean Return-1.04Value At Risk-9.68
Potential Upside7.60Standard Deviation7.04
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of T2 Biosystms historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

T2 Biosystms Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as T2 Biosystms is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading T2 Biosystms backward and forwards among themselves. T2 Biosystms' institutional investor refers to the entity that pools money to purchase T2 Biosystms' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Altium Capital Management Lp2022-09-30Common Shares2.8 M321 K
Vanguard Group Inc2022-12-31Common Shares175.4 K249.1 K
Principal Financial Group Inc2022-03-31Common Shares177.8 K93 K
Gagnon Securities Llc2022-09-30Common Shares766.3 K87 K
Bank Of New York Mellon Corp2022-12-31Common Shares60.3 K85.6 K
Millennium Management Llc2022-06-30Common Shares453.7 K73 K
Blackrock Inc2022-12-31Common Shares51.3 K72.8 K
Mcadam Llc2022-12-31Common Shares113.2 K58 K
Susquehanna International Group Llp2022-12-31Call Options39.4 K55.9 K
Ifp Advisors Inc2022-12-31Common Shares6.4 K55 K
Virtu Financial Llc2022-06-30Common Shares323.4 K52 K
Note, although T2 Biosystms' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

T2 Biosystms Cash Flow Accounts

201820192020202120222023 (projected)
Capital Expenditure(593 K)(761 K)(800 K)(460 K)(529 K)(570.76 K)
Depreciation Amortization and Accretion2.45 M3.64 M3.16 M2.54 M2.92 M2.71 M
Net Cash Flow or Change in Cash and Cash Equivalents8.93 M(39.77 M)6.13 M6.45 M5.81 M6.27 M
Issuance Purchase of Equity Shares51.2 M7.23 M85.61 M20.54 M23.62 M28.56 M
Issuance Repayment of Debt Securities11.4 M(1.19 M)(1.55 M)(882 K)(793.8 K)(814.69 K)
Net Cash Flow from Financing49.66 M6.35 M85.61 M20.54 M23.62 M35.3 M
Net Cash Flow from Investing(593 K)(761 K)(36.26 M)24.79 M28.51 M30.76 M
Net Cash Flow from Operations(40.14 M)(45.36 M)(43.22 M)(38.87 M)(34.99 M)(37.75 M)
Share Based Compensation9.9 M5.46 M3.91 M7.09 M8.15 M6.77 M

T2 Biosystms Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to T2 Biosystms or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that T2 Biosystms' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a T2 Biosystms stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over NYSE Composite
Beta against NYSE Composite2.06
Overall volatility
Information ratio -0.15

T2 Biosystms Volatility Alert

T2 Biosystms is displaying above-average volatility over the selected time horizon. Investors should scrutinize T2 Biosystms independently to ensure intended market timing strategies are aligned with expectations about T2 Biosystms volatility. T2 Biosystms is a potential penny stock. Although T2 Biosystms may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in T2 Biosystms. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on T2 Biosystms instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

T2 Biosystms Fundamentals Vs Peers

Comparing T2 Biosystms' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze T2 Biosystms' direct or indirect competition across all of the common fundamentals between T2 Biosystms and the related equities. This way, we can detect undervalued stocks with similar characteristics as T2 Biosystms or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of T2 Biosystms' fundamental indicators could also be used in its relative valuation, which is a method of valuing T2 Biosystms by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare T2 Biosystms to competition
FundamentalsT2 BiosystmsPeer Average
Return On Equity(6.22) %(0.31) %
Return On Asset(0.73) %(0.14) %
Profit Margin(2.79) %(1.27) %
Operating Margin(2.49) %(5.51) %
Current Valuation49.08 M16.62 B
Shares Outstanding16.73 M571.82 M
Shares Owned by Insiders2.18 %10.09 %
Shares Owned by Institutions18.46 %39.21 %
Number of Shares Shorted524.31 K4.71 M
Price to Earning(2.04) X28.72 X
Price to Book14.50 X9.51 X
Price to Sales0.40 X11.42 X
Revenue28.06 M9.43 B
Gross Profit(24.77 M)27.38 B
EBITDA(40.12 M)3.9 B
Net Income(49.24 M)570.98 M
Cash and Equivalents13.21 M2.7 B
Cash per Share1.87 X5.01 X
Total Debt47.79 M5.32 B
Debt to Equity6.64 %48.70 %
Current Ratio1.87 X2.16 X
Book Value Per Share(5.18) X1.93 K
Cash Flow from Operations(38.87 M)971.22 M
Short Ratio0.61 X4.00 X
Earnings Per Share(12.66) X3.12 X
Target Price0.57
Number of Employees16018.84 K
Market Capitalization8.37 M19.03 B
Total Asset60.54 M29.47 B
Retained Earnings(184.73 M)9.33 B
Working Capital59.25 M1.48 B
Current Asset77.78 M9.34 B
   Exercise or conversion by Sperzel John J Iii of 16000 shares of T2 Biosystms subject to Rule 16b-3 [view details]

T2 Biosystms Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as T2 Biosystms . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About T2 Biosystms Buy or Sell Advice

When is the right time to buy or sell T2 Biosystms? Buying financial instruments such as T2 Biosystms Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2020 2021 2022 2023 (projected)
Receivables5.1 M5.13 M4.62 M4.99 M
Inventories3.64 M3.91 M3.52 M3.8 M

Use Investing Ideas to Build Portfolios

In addition to having T2 Biosystms in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Gainers Thematic Idea Now

Latest Gainers
Latest Gainers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Gainers theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Gainers Theme or any other thematic opportunities.
View All  Next Launch
Check out T2 Biosystms Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in T2 Biosystms Stock please use our How to Invest in T2 Biosystms guide. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for analysis

When running T2 Biosystms price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know T2 Biosystms will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of T2 Biosystms is measured differently than its book value, which is the value of T2 Biosystms that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine T2 Biosystms value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.